Obesity, metabolic syndrome, and dietary therapeutical approaches with a special focus on nutraceuticals (polyphenols): A mini-review

International Journal for Vitamin and Nutrition Research

Volumn 84, Issue 3-4, 2015, Pages 113-123

  Ríos Hoyo, Alejandro ^a   Cortés, María José ^a   Ríos Ontiveros, Huguette ^a   Meaney, Eduardo ^b   Ceballos, Guillermo ^b   Gutiérrez Salmeán, Gabriela ^a,b  

^a UNIVERSIDAD ANÁHUAC   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Cardiovascular risk; Metabolic syndrome; Nutraceuticals; Nutrition; Polyphenols

Indexed keywords

NUTRACEUTICAL; POLYPHENOL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; FIBRINOLYTIC AGENT; VASODILATOR AGENT;

ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; HUMAN; MEDITERRANEAN DIET; METABOLIC SYNDROME X; METABOLISM; NUTRIENT; NUTRITION; OBESITY; PHYSICAL INACTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SYSTEMATIC REVIEW (TOPIC); TOBACCO USE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIET; DRUG EFFECTS; HEALTH CARE POLICY; PATIENT COMPLIANCE;

ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DIET; DIET, MEDITERRANEAN; DIETARY SUPPLEMENTS; FIBRINOLYTIC AGENTS; HUMANS; METABOLIC SYNDROME X; NUTRITION POLICY; OBESITY; PATIENT COMPLIANCE; POLYPHENOLS; VASODILATOR AGENTS;

EID: 84930171247     PISSN: 03009831     EISSN: 16642821     Source Type: Journal    
DOI: 10.1024/0300-9831/a000198     Document Type: Review

References (104)

1. New WHO report: deaths from noncommunicable diseases on the rise, with developing world hit hardest (2011). Cent Eur J Public Health. 19, 2.
2. World Health Organization (2014). The top 10 causes of death. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/
3. Gutiérrez JP, Rivera-Dommarco J, Shamah-Levy T, Villalpando-Hernández S, Cuevas-Nasu L, et al. (2012) Encuesta Nacional de Salud y Nutrición 2012. Resultados Nacionales. Cuernavaca, México; Instituto Nacional de Salud Pública.
4. Cooney, M.T. (2011) Total cardiovascular disease risk assessment: a review. Curr Opin Cardiol. 26, 5.
5. Murakami, Y. (2012) Diabetes, body mass index and the excess risk of coronary heart disease, ischemic and hemorrhagic stroke in the Asia Pacific Cohort Studies Collaboration. Prev Med. 54, 1.
6. Nguyen, D.M. and El-Serag, H.B. (2010) The epidemiology of obesity. Gastroenterol Clin North Am. 39, 1.
7. Popkin, B.M., Adair, L.S., and Ng, S.W. (2012) Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 70, 1.
8. Redinger, R.N. (2008) The prevalence and etiology of nongenetic obesity and associated disorders. South Med J. 101, 4.
9. Guo, X. (2014). An update on overweight and obesity in rural Northeast China: from lifestyle risk factors to cardiometabolic comorbidities. BMC Public Health. 14: 1046
10. Grundy, S.M. (2007) Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab. 92, 2.
11. Rasouli, N., and Kern, P.A. (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab. 93, 11.
12. Weisberg, S.P. (2003). Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 112, 12.
13. Itani, S.I. (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 51, 7.
14. Duvnjak, L., and Duvnjak, M. (2009) The metabolic syndrome - an ongoing story. J Physiol Pharmacol. 60, Suppl 7, 19.
15. Montagnani, M., and Quon, M.J. (2000) Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension. Diabetes Obes Metab. 2, 5.
16. Zheng, H. (2009) Fat and cholesterol diet induced lipid metabolic disorders and insulin resistance in rabbit. Exp Clin Endocrinol Diabetes. 117, 8.
17. Ageeva, V.V. (2002) Interconnection between insulin resistance and lipid metabolism disorders in obese patients. Ter Arkh. 74, 10.
18. Foster, R.H. and Wilson, N. (2013) Review of the evidence for the potential impact and feasibility of substituting saturated fat in the New Zealand diet. Aust N Z J Public Health 37, 4.
19. Lamarche, B. and P. Couture. (2014) It is time to revisit current dietary recommendations for saturated fat. Appl Physiol Nutr Metab 39, 14.
20. Schwingshackl, L. and Hoffmann, G. (2013) Longterm effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis. Nutr J. 12.
21. Weihua Mmed, L., W. Yougang, and W. Jing. (2013) Reduced or modified dietary fat for preventing cardiovascular disease. J Cardiovasc Nurs 28, 3.
22. Campbell, N., et al. (2011) New evidence relating to the health impact of reducing salt intake. Nutr Metab Cardiovasc Dis 21, 9.
23. He, F.J., J. Li, and G.A. Macgregor. (2013) Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 346: f1325.
24. Taylor, R.S., et al. (2011) Reduced dietary salt for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials (Cochrane review). Am J Hypertens 24, 8.
25. Johansson, K., Neovius, M., and Hemmingsson, E. (2014) Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and metaanalysis of randomized controlled trials. Am J Clin Nutr. 99, 1.
26. Sacks, F.M. (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 360, 9.
27. Hession, M. (2009) Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/lowcalorie diets in the management of obesity and its comorbidities. Obes Rev. 10, 1.
28. Brinkworth, G.D. (2009) Long-term effects of a verylow-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr. 90, 1.
29. Schwingshackl, L. and Hoffmann, G. (2013) Longterm effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis. Nutr J. 12, 48.
30. Eckel, R.H., (2014) 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 63, 25 Pt B.
31. Cole, J.A. (2011) Systematic review of the effect of diet and exercise lifestyle interventions in the secondary prevention of coronary heart disease. Cardiol Res Pract. 232351.
32. Chang, J., Luo, J. and He, G. (2009) Regulation of polyphenols accumulation by combined overexpression/silencing key enzymes of phenylpropanoid pathway. Acta Biochim Biophys Sin (Shanghai). 41, 2.
33. Bravo, L. (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 11.
34. Tsao, R. (2010) Chemistry and biochemistry of dietary polyphenols. Nutrients. 2, 12.
35. Manach, C. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr. 79, 5.
36. Perez-Jimenez, J. (2010) Identification of the 100 richest dietary sources of polyphenols: an application of the Phenol-Explorer database. Eur J Clin Nutr. 64, Suppl 3, S112-120.
37. Neveu, V., et al., Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford), 2010. 2010: p. bap024.
38. Sampson, L., et al. (2002) Flavanol and flavone intakes in US health professionals. J Am Diet Assoc. 102,10.
39. Hertog, M.G., et al. (1993) Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer. 20, 1.
40. Zamora-Ros, R. (2010) Estimation of dietary sources and flavonoid intake in a Spanish adult population (EPIC-Spain). J Am Diet Assoc. 110, 3.
41. Mursu, J., et al. (2008) Intake of flavonoids and risk of cancer in Finnish men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Int J Cancer. 123, 3
42. Kimira, M., et al. (1998) Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol. 8, 3.
43. Casas, R. (2014) The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. PLoS One. 9, 6.
44. Garcia-Fernandez, E. (2014) Mediterranean diet and cardiodiabesity: a review. Nutrients. 6, 9.
45. Holt, R.R. (2012) The potential of flavanol and procyanidin intake to influence age-related vascular disease. J Nutr Gerontol Geriatr. 31, 3.
46. Peterson, J.J. (2012) Associations between flavonoids and cardiovascular disease incidence or mortality in European and US populations. Nutr Rev, 70, 9.
47. Tresserra-Rimbau, A. (2014) Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial. BMC Med. 12, 77.
48. Tapsell, L.C. (2014) Foods and food components in the Mediterranean diet: supporting overall effects. BMC Med. 12, 100.
49. Estruch, R., et al. (2013) Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 368, 14.
50. de Lorgeril, M., et al. (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 99, 6.
51. Estruch, R., et al. (2006) Effects of a Mediterraneanstyle diet on cardiovascular risk factors: a randomized trial. Ann Intern Med. 145, 1.
52. Widmer, R.J., et al. (2014) The Mediterranean Diet, its Components, and Cardiovascular Disease. Am J Med. 128, 229.
53. Domenech, M. (2014) Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids: one-year randomized, clinical trial. Hypertension. 64, 1.
54. Simopoulos, A.P., (2001) The Mediterranean diets: What is so special about the diet of Greece? The scientific evidence. J Nutr 131, S1.
55. Rodrigo, R., A. Miranda, and L. Vergara. (2011) Modulation of endogenous antioxidant system by wine polyphenols in human disease. Clin Chim Acta. 412, 5-6.
56. Mladenka, P., et al. (2010) Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radic Biol Med 49, 6.
57. Hollman, P.C., et al. (2011) The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr. 141, 5.
58. Jung, K.H., et al. (2008) Epigallocatechin gallate stimulates glucose uptake through the phosphatidylinositol 3-kinase-mediated pathway in L6 rat skeletal muscle cells. J Med Food. 11, 3.
59. Kim, J.A., et al. (2007) Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem. 282, 18.
60. Rizza, S., et al. (2011) Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab. 96, 5.
61. Bhardwaj, P., Khanna, D. and Balakumar, P. (2014) Catechin averts experimental diabetes mellitusinduced vascular endothelial structural and functional abnormalities. Cardiovasc Toxicol, 2014. 14(1): p. 41-51.
62. Venkatachalam, K., et al. (2008) Resveratrol inhibits high glucose-induced PI3K/Akt/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am J Physiol Heart Circ Physiol. 294, 5.
63. Reiter, C.E., Kim, J.A., and Quon, M.J. (2010) Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1. Endocrinology, 2010. 151. 1.
64. Andriantsitohaina, R., et al. (2012) Molecular mechanisms of the cardiovascular protective effects of polyphenols. Br J Nutr. 108, 9
65. Gutierrez-Salmean, G., et al. (2014) Acute effects of an oral supplement of (-)-epicatechin on postprandial fat and carbohydrate metabolism in normal and overweight subjects. Food Funct. 5, 521-527.
66. Collins, Q.F., et al. (2007) Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase. J Biol Chem, 282, 4.
67. Cordero-Herrera, I., et al. (2013) Cocoa flavonoids improve insulin signalling and modulate glucose production via AKT and AMPK in HepG2 cells. Mol Nutr Food Res. 57, 6.
68. de Lange, D.W., et al. (2007) Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox. Alcohol Clin Exp Res. 31, 8.
69. Khurana, S., et al. (2013) Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients. 5, 10.
70. Mattiello, T., et al. (2009) Effects of pomegranate juice and extract polyphenols on platelet function. J Med Food 12, 2.
71. Quinones, M., Miguel, M., and Aleixandre, A. (2013) Beneficial effects of polyphenols on cardiovascular disease. Pharmacol Res. 68, 1.
72. Lancon, A., et al. (2012) Control of MicroRNA expression as a new way for resveratrol to deliver its beneficial effects. J Agric Food Chem 60, 36.
73. Nicholson, S.K., Tucker, G.A. and Brameld, J.M. (2008) Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc. 67, 1.
74. Milenkovic, D., et al. (2014) Dietary flavanols modulate the transcription of genes associated with cardiovascular pathology without changes in their DNA methylation state. PLoS One. 9, 4.
75. Duthie, S.J. (2011) Epigenetic modifications and human pathologies: cancer and CVD. Proc Nutr Soc. 70, 1.
76. Crescenti, A. (2013) Cocoa consumption alters the global DNA methylation of peripheral leukocytes in humans with cardiovascular disease risk factors: a randomized controlled trial. PLoS One. 8, 6.
77. Baselga-Escudero, L., et al. (2014) Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells. Nucleic Acids Res. 42, 2.
78. Chung, S., et al. (2010) Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys. 501, 1.
79. Gutierrez-Salmean, G., et al. (2014) Effects of (-)-epicatechin on a diet-induced rat model of cardiometabolic risk factors. Eur J Pharmacol. 728, 24.
80. Peng, X., et al. (2014) Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials. Sci Rep. 4, 6251.
81. Khalesi, S., et al.,(2014) Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur J Nutr. 53, 6.
82. Onakpoya, I., et al. (2014) The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis, 24, 8.
83. Ried, K., et al. (2010) Does chocolate reduce blood pressure? A meta-analysis. BMC Med. 8., 39.
84. Desch, S., et al. (2010) Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens. 23, 1.
85. Hooper, L., et al. (2012) Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 95, 3.
86. Kim, A., et al. (2011) Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc. 111, 11.
87. Zheng, X.X., et al. (2011) Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr. 94, 2.
88. Tokede, O.A., J.M. Gaziano, and L. Djousse. (2011) Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. Eur J Clin Nutr. 65, 8.
89. Jia, L., et al. (2010) Short-term effect of cocoa product consumption on lipid profile: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 92, 1.
90. Anderson, J.W., B.M. Johnstone, and M. E. Cook-Newell. (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med. 333, 5.
91. Zhan, S. and S.C. Ho. (2005) Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 81, 2.
92. Shrime, M.G., et al., (2011) Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr,. 141, 11.
93. Liu, K., et al., (2013) Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr. 98, 2.
94. Jing, Y., et al., (2009) Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies. J Gen Intern Med. 24, 5.
95. Jurgens, T.M., et al. (2012) Green tea for weight loss and weight maintenance in overweight or obese adults. Cochrane Database Syst Rev. 12, 12.
96. Hursel, R., W. Viechtbauer, and M.S. Westerterp-Plantenga. (2009) The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int J Obes (Lond). 33, 9
97. Murphy, K.J., et al., Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr, 2003. 77(6): p. 1466-73.
98. Petyaev, I.M., et al., Reduction in blood pressure and serum lipids by lycosome formulation of dark chocolate and lycopene in prehypertension. Food Sci Nutr, 2014. 2(6): p. 744-50.
99. Nickols-Richardson, S.M., et al., Changes in body weight, blood pressure and selected metabolic biomarkers with an energy-restricted diet including twice daily sweet snacks and once daily sugar-free beverage. Nutr Res Pract, 2014. 8(6): p. 695-704.
100. Alleyne, T., et al., Short Term Effects of Cocoa Consumption on Blood Pressure. West Indian Med J, 2013. 63(4): p. 316-321.
101. de Jesus Romero-Prado, M.M., et al. (in press) Dietary Flavonoids Added To Pharmacological Antihypertensive Therapy Are Effective In Improving Blood Pressure. Basic Clin Pharmacol Toxicol. doi: 10.1111/bcpt.12360.
102. Chen, C.Y., et al., Avenanthramides are bioavailable and have antioxidant activity in humans after acute consumption of an enriched mixture from oats. J Nutr, 2007. 137(6): p. 1375-82.
103. Cardona, F., et al. (2013) Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem, 24, 8.
104. Monagas, M., et al., (2009) Dihydroxylated phenolic acids derived from microbial metabolism reduce lipopolysaccharide-stimulated cytokine secretion by human peripheral blood mononuclear cells. Br J Nutr. 102, 2.